Topic: S666

The Project BioShield Act of 2004, originally initiated through Senate bill S666, is identified as a legal framework allowing the government to bypass vaccine testing during declared emergencies. This legislation provides pharmaceutical companies and government agencies immunity from lawsuits related to vaccine injuries. Critics argue the law is being reinterpreted to classify H1N1 as a biological threat to expedite unproven medical treatments.